These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 17545189
21. Antimalarials may influence the risk of malignancy in systemic lupus erythematosus. Ruiz-Irastorza G, Ugarte A, Egurbide MV, Garmendia M, Pijoan JI, Martinez-Berriotxoa A, Aguirre C. Ann Rheum Dis; 2007 Jun; 66(6):815-7. PubMed ID: 17204564 [Abstract] [Full Text] [Related]
22. Medication use in systemic lupus erythematosus. Bernatsky S, Peschken C, Fortin PR, Pineau CA, Urowitz MB, Gladman DD, Pope JE, Hudson M, Zummer M, Smith CD, Arbillaga HO, Clarke AE, Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS). J Rheumatol; 2011 Feb; 38(2):271-4. PubMed ID: 21078722 [Abstract] [Full Text] [Related]
23. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N. J Rheumatol; 2002 Feb; 29(2):282-7. PubMed ID: 11838845 [Abstract] [Full Text] [Related]
24. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. Mok MY, Lo Y, Chan TM, Wong WS, Lau CS. J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014 [Abstract] [Full Text] [Related]
26. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, Simonneau G, Humbert M. Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255 [Abstract] [Full Text] [Related]
27. Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. Bernatsky S, Boivin JF, Joseph L, St Pierre Y, Moore A, Rajan R, Clarke A. J Rheumatol; 2002 Dec; 29(12):2551-4. PubMed ID: 12465150 [Abstract] [Full Text] [Related]
28. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus. Vlachoyiannopoulos PG, Toya SP, Katsifis G, Zintzaras E, Tzioufas AG, Moutsopoulos HM. J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157 [Abstract] [Full Text] [Related]
29. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED. J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514 [Abstract] [Full Text] [Related]
30. Childhood agricultural and adult occupational exposures to organic dusts in a population-based case-control study of systemic lupus erythematosus. Parks CG, Cooper GS, Dooley MA, Park MM, Treadwell EL, Gilkeson GS. Lupus; 2008 Aug; 17(8):711-9. PubMed ID: 18625648 [Abstract] [Full Text] [Related]
31. Hodgkin's lymphoma in systemic lupus erythematosus. Bernatsky S, Ramsey-Goldman R, Isenberg D, Rahman A, Dooley MA, Sibley J, Boivin JF, Joseph L, Armitage J, Zoma A, Clarke A. Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135 [Abstract] [Full Text] [Related]
32. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Jung H, Bobba R, Su J, Shariati-Sarabi Z, Gladman DD, Urowitz M, Lou W, Fortin PR. Arthritis Rheum; 2010 Mar; 62(3):863-8. PubMed ID: 20131232 [Abstract] [Full Text] [Related]
33. Immunosuppressive drug therapy of systemic lupus erythematosus. Fox DA, McCune WJ. Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402 [Abstract] [Full Text] [Related]
34. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM. Arthritis Rheum; 2009 Jan 15; 61(1):29-36. PubMed ID: 19116963 [Abstract] [Full Text] [Related]
35. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study. Manger K, Wildt L, Kalden JR, Manger B. Autoimmun Rev; 2006 Apr 15; 5(4):269-72. PubMed ID: 16697968 [Abstract] [Full Text] [Related]
36. Do traditional Gail model risk factors account for increased breast cancer in women with lupus? Bernatsky S, Ramsey-Goldman R, Boivin JF, Joseph L, Moore AD, Rajan R, Clarke A. J Rheumatol; 2003 Jul 15; 30(7):1505-7. PubMed ID: 12858448 [Abstract] [Full Text] [Related]
37. A case of systemic lupus erythematosus presenting with protein-losing enteropathy. Türkçapar N, Ozyüncü N, Cinar K, Ensari A, Küçük O, Idilman R, Duman N, Ozden A. Turk J Gastroenterol; 2006 Sep 15; 17(3):226-30. PubMed ID: 16941261 [Abstract] [Full Text] [Related]
38. Micronucleus frequency in peripheral blood lymphocytes from patients with systemic lupus erythematosus. Severin E. Rom J Morphol Embryol; 1995 Sep 15; 41(1-2):55-8. PubMed ID: 8680026 [Abstract] [Full Text] [Related]
39. Moderate and severe neutropenia in patients with systemic lupus erythematosus. Martínez-Baños D, Crispín JC, Lazo-Langner A, Sánchez-Guerrero J. Rheumatology (Oxford); 2006 Aug 15; 45(8):994-8. PubMed ID: 16484291 [Abstract] [Full Text] [Related]
40. Occupational exposures and ovarian cancer in textile workers. Wernli KJ, Ray RM, Gao DL, Fitzgibbons ED, Camp JE, Astrakianakis G, Seixas N, Wong EY, Li W, De Roos AJ, Feng Z, Thomas DB, Checkoway H. Epidemiology; 2008 Mar 15; 19(2):244-50. PubMed ID: 18300714 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]